Do analysts prefer DRMA or JAGX?

Dermata Therapeutics currently has a consensus target price of $10.00, suggesting a potential upside of 687.40%. Given Dermata Therapeutics' stronger consensus rating and higher possible upside, research analysts clearly believe Dermata Therapeutics is more favorable than Jaguar Animal Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dermata Therapeutics 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer NCNA or JAGX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NuCana 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer JAGX or CDIO?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Cardio Diagnostics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media prefer JAGX or CDIO?

In the previous week, Jaguar Animal Health and Jaguar Animal Health both had 1 articles in the media. Jaguar Animal Health's average media sentiment score of 0.00 equaled Cardio Diagnostics'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Jaguar Animal Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cardio Diagnostics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate JAGX or SNGX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Soligenix 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate JAGX or BMRA?

Biomerica has a consensus target price of $9.00, indicating a potential upside of 462.50%. Given Biomerica's higher possible upside, analysts plainly believe Biomerica is more favorable than Jaguar Animal Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Biomerica 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Jaguar Animal Health (JAGX) Competitors

$1.26 -0.04 (-2.69%)

Closing price 07/20/2026 03:59 PM Eastern

Extended Trading

$1.20 -0.06 (-4.74%)

As of 04:00 AM Eastern

Compare

JAGX vs. DRMA, NCNA, CDIO, SNGX, and BMRA

Should you buy Jaguar Animal Health stock or one of its competitors? MarketBeat compares Jaguar Animal Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Jaguar Animal Health include Dermata Therapeutics (DRMA), NuCana (NCNA), Cardio Diagnostics (CDIO), Soligenix (SNGX), and Biomerica (BMRA). These companies are all part of the "pharmaceutical products" industry.

How does Jaguar Animal Health compare to Dermata Therapeutics?

Dermata Therapeutics (NASDAQ:DRMA) and Jaguar Animal Health (NASDAQ:JAGX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, media sentiment, valuation, earnings, dividends, analyst recommendations and risk.

Dermata Therapeutics currently has a consensus target price of $10.00, suggesting a potential upside of 687.40%. Given Dermata Therapeutics' stronger consensus rating and higher possible upside, research analysts clearly believe Dermata Therapeutics is more favorable than Jaguar Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dermata Therapeutics	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Dermata Therapeutics has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -169.04%. Jaguar Animal Health's return on equity of 0.00% beat Dermata Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dermata Therapeutics	N/A	-127.91%	-105.05%
Jaguar Animal Health	-169.04%	N/A	-115.55%

Dermata Therapeutics has a beta of 0.67, indicating that its stock price is 33% less volatile than the broader market. Comparatively, Jaguar Animal Health has a beta of -0.11, indicating that its stock price is 111% less volatile than the broader market.

Dermata Therapeutics has higher earnings, but lower revenue than Jaguar Animal Health. Dermata Therapeutics is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dermata Therapeutics	N/A	N/A	-$7.56M	-$5.31	N/A
Jaguar Animal Health	$11.51M	0.07	-$53.43M	-$591.92	N/A

In the previous week, Jaguar Animal Health had 1 more articles in the media than Dermata Therapeutics. MarketBeat recorded 1 mentions for Jaguar Animal Health and 0 mentions for Dermata Therapeutics. Dermata Therapeutics' average media sentiment score of 0.00 equaled Jaguar Animal Health'saverage media sentiment score.

Company	Overall Sentiment
Dermata Therapeutics	Neutral
Jaguar Animal Health	Neutral

8.7% of Dermata Therapeutics shares are owned by institutional investors. Comparatively, 12.0% of Jaguar Animal Health shares are owned by institutional investors. 21.9% of Dermata Therapeutics shares are owned by insiders. Comparatively, 2.0% of Jaguar Animal Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Dermata Therapeutics beats Jaguar Animal Health on 9 of the 14 factors compared between the two stocks.

How does Jaguar Animal Health compare to NuCana?

NuCana (NASDAQ:NCNA) and Jaguar Animal Health (NASDAQ:JAGX) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, institutional ownership, earnings, analyst recommendations and profitability.

44.0% of NuCana shares are held by institutional investors. Comparatively, 12.0% of Jaguar Animal Health shares are held by institutional investors. 31.2% of NuCana shares are held by insiders. Comparatively, 2.0% of Jaguar Animal Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NuCana	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

NuCana has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -169.04%. Jaguar Animal Health's return on equity of 0.00% beat NuCana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NuCana	N/A	-153.61%	-116.03%
Jaguar Animal Health	-169.04%	N/A	-115.55%

NuCana has higher earnings, but lower revenue than Jaguar Animal Health. NuCana is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NuCana	N/A	N/A	-$38.71M	-$2.98	N/A
Jaguar Animal Health	$11.51M	0.07	-$53.43M	-$591.92	N/A

In the previous week, Jaguar Animal Health had 1 more articles in the media than NuCana. MarketBeat recorded 1 mentions for Jaguar Animal Health and 0 mentions for NuCana. NuCana's average media sentiment score of 0.00 equaled Jaguar Animal Health'saverage media sentiment score.

Company	Overall Sentiment
NuCana	Neutral
Jaguar Animal Health	Neutral

NuCana has a beta of 2.23, suggesting that its stock price is 123% more volatile than the broader market. Comparatively, Jaguar Animal Health has a beta of -0.11, suggesting that its stock price is 111% less volatile than the broader market.

Summary

NuCana beats Jaguar Animal Health on 6 of the 11 factors compared between the two stocks.

How does Jaguar Animal Health compare to Cardio Diagnostics?

Jaguar Animal Health (NASDAQ:JAGX) and Cardio Diagnostics (NASDAQ:CDIO) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership.

12.0% of Jaguar Animal Health shares are owned by institutional investors. Comparatively, 8.1% of Cardio Diagnostics shares are owned by institutional investors. 2.0% of Jaguar Animal Health shares are owned by company insiders. Comparatively, 13.3% of Cardio Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Jaguar Animal Health has a net margin of -169.04% compared to Cardio Diagnostics' net margin of -36,950.00%. Jaguar Animal Health's return on equity of 0.00% beat Cardio Diagnostics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jaguar Animal Health	-169.04%	N/A	-115.55%
Cardio Diagnostics	-36,950.00%	-78.82%	-72.87%

Cardio Diagnostics has lower revenue, but higher earnings than Jaguar Animal Health. Cardio Diagnostics is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jaguar Animal Health	$11.51M	0.07	-$53.43M	-$591.92	N/A
Cardio Diagnostics	$10K	482.48	-$6.50M	-$3.38	N/A

In the previous week, Jaguar Animal Health and Jaguar Animal Health both had 1 articles in the media. Jaguar Animal Health's average media sentiment score of 0.00 equaled Cardio Diagnostics'average media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Jaguar Animal Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cardio Diagnostics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Cardio Diagnostics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Jaguar Animal Health has a beta of -0.11, indicating that its stock price is 111% less volatile than the broader market. Comparatively, Cardio Diagnostics has a beta of 2.23, indicating that its stock price is 123% more volatile than the broader market.

Summary

Cardio Diagnostics beats Jaguar Animal Health on 6 of the 11 factors compared between the two stocks.

How does Jaguar Animal Health compare to Soligenix?

Jaguar Animal Health (NASDAQ:JAGX) and Soligenix (NASDAQ:SNGX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, risk, media sentiment, earnings and institutional ownership.

Soligenix has lower revenue, but higher earnings than Jaguar Animal Health. Soligenix is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jaguar Animal Health	$11.51M	0.07	-$53.43M	-$591.92	N/A
Soligenix	$120K	44.26	-$11.08M	-$1.68	N/A

In the previous week, Jaguar Animal Health had 1 more articles in the media than Soligenix. MarketBeat recorded 1 mentions for Jaguar Animal Health and 0 mentions for Soligenix. Jaguar Animal Health's average media sentiment score of 0.00 equaled Soligenix'saverage media sentiment score.

Company	Overall Sentiment
Jaguar Animal Health	Neutral
Soligenix	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Soligenix	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

12.0% of Jaguar Animal Health shares are owned by institutional investors. Comparatively, 3.6% of Soligenix shares are owned by institutional investors. 2.0% of Jaguar Animal Health shares are owned by insiders. Comparatively, 3.1% of Soligenix shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Soligenix has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -169.04%. Jaguar Animal Health's return on equity of 0.00% beat Soligenix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jaguar Animal Health	-169.04%	N/A	-115.55%
Soligenix	N/A	-244.73%	-131.22%

Jaguar Animal Health has a beta of -0.11, indicating that its stock price is 111% less volatile than the broader market. Comparatively, Soligenix has a beta of 1.92, indicating that its stock price is 92% more volatile than the broader market.

Summary

Jaguar Animal Health and Soligenix tied by winning 6 of the 12 factors compared between the two stocks.

How does Jaguar Animal Health compare to Biomerica?

Jaguar Animal Health (NASDAQ:JAGX) and Biomerica (NASDAQ:BMRA) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.

Jaguar Animal Health has a beta of -0.11, indicating that its share price is 111% less volatile than the broader market. Comparatively, Biomerica has a beta of 0.33, indicating that its share price is 67% less volatile than the broader market.

In the previous week, Jaguar Animal Health had 1 more articles in the media than Biomerica. MarketBeat recorded 1 mentions for Jaguar Animal Health and 0 mentions for Biomerica. Jaguar Animal Health's average media sentiment score of 0.00 equaled Biomerica'saverage media sentiment score.

Company	Overall Sentiment
Jaguar Animal Health	Neutral
Biomerica	Neutral

12.0% of Jaguar Animal Health shares are owned by institutional investors. Comparatively, 22.3% of Biomerica shares are owned by institutional investors. 2.0% of Jaguar Animal Health shares are owned by company insiders. Comparatively, 18.0% of Biomerica shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Biomerica has a consensus target price of $9.00, indicating a potential upside of 462.50%. Given Biomerica's higher possible upside, analysts plainly believe Biomerica is more favorable than Jaguar Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Biomerica	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Biomerica has lower revenue, but higher earnings than Jaguar Animal Health. Biomerica is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jaguar Animal Health	$11.51M	0.07	-$53.43M	-$591.92	N/A
Biomerica	$4.33M	1.14	-$4.97M	-$0.89	N/A

Biomerica has a net margin of -96.49% compared to Jaguar Animal Health's net margin of -169.04%. Jaguar Animal Health's return on equity of 0.00% beat Biomerica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jaguar Animal Health	-169.04%	N/A	-115.55%
Biomerica	-96.49%	-98.14%	-70.42%

Summary

Biomerica beats Jaguar Animal Health on 9 of the 13 factors compared between the two stocks.

Get Jaguar Animal Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding JAGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

JAGX vs. The Competition

Export

Metric	Jaguar Animal Health	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$780K	$3.07B	$6.89B	$12.28B
Dividend Yield	N/A	2.05%	2.67%	9.39%
P/E Ratio	0.00	20.20	27.07	23.94
Price / Sales	0.07	340.68	515.45	90.30
Price / Cash	N/A	27.11	26.68	47.25
Price / Book	-0.01	4.20	10.42	6.14
Net Income	-$53.43M	$65.94M	$3.60B	$331.74M
7 Day Performance	-41.71%	-3.05%	-1.26%	-1.81%
1 Month Performance	-43.78%	-1.30%	1.07%	-1.44%
1 Year Performance	-98.50%	15.22%	23.61%	16.33%

Jaguar Animal Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
JAGX Jaguar Animal Health	0.0313 of 5 stars	$1.27 -2.7%	N/A	-98.4%	$780K	$11.51M	N/A	50	News Coverage Positive News Gap Down
DRMA Dermata Therapeutics	2.0776 of 5 stars	$1.32 -2.2%	$10.00 +657.6%	-81.2%	$5.43M	N/A	N/A	8	Gap Down
NCNA NuCana	0.7293 of 5 stars	$1.31 +2.3%	N/A	-86.3%	$5.33M	N/A	N/A	30	Positive News
CDIO Cardio Diagnostics	0.2444 of 5 stars	$1.80 +0.6%	N/A	-62.1%	$5.30M	$10K	N/A	1	Gap Up
SNGX Soligenix	0.7565 of 5 stars	$0.37 +4.8%	$6.00 +1,522.1%	-73.6%	$5.23M	$120K	N/A	20	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:JAGX) was last updated on 7/21/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Jaguar Animal Health (JAGX) Competitors

JAGX vs. DRMA, NCNA, CDIO, SNGX, and BMRA

How does Jaguar Animal Health compare to Dermata Therapeutics?

Summary

How does Jaguar Animal Health compare to NuCana?

Summary

How does Jaguar Animal Health compare to Cardio Diagnostics?

Summary

How does Jaguar Animal Health compare to Soligenix?

Summary

How does Jaguar Animal Health compare to Biomerica?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

JAGX vs. The Competition

Jaguar Animal Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Jaguar Animal Health (JAGX) Competitors

JAGX vs. DRMA, NCNA, CDIO, SNGX, and BMRA

How does Jaguar Animal Health compare to Dermata Therapeutics?

Do analysts prefer DRMA or JAGX?

Is DRMA or JAGX more profitable?

Which has more volatility and risk, DRMA or JAGX?

Which has stronger earnings & valuation, DRMA or JAGX?

Does the media refer more to DRMA or JAGX?

Do institutionals & insiders hold more shares of DRMA or JAGX?

Summary

How does Jaguar Animal Health compare to NuCana?

Do institutionals and insiders hold more shares of NCNA or JAGX?

Do analysts prefer NCNA or JAGX?

Is NCNA or JAGX more profitable?

Which has preferable valuation & earnings, NCNA or JAGX?

Does the media favor NCNA or JAGX?

Which has more volatility & risk, NCNA or JAGX?

Summary

How does Jaguar Animal Health compare to Cardio Diagnostics?

Do institutionals & insiders have more ownership in JAGX or CDIO?

Is JAGX or CDIO more profitable?

Which has higher valuation & earnings, JAGX or CDIO?

Does the media prefer JAGX or CDIO?

Do analysts prefer JAGX or CDIO?

Which has more risk and volatility, JAGX or CDIO?

Summary

How does Jaguar Animal Health compare to Soligenix?

Which has stronger earnings and valuation, JAGX or SNGX?

Does the media prefer JAGX or SNGX?

Do analysts rate JAGX or SNGX?

Do insiders & institutionals have more ownership in JAGX or SNGX?

Is JAGX or SNGX more profitable?

Which has more risk & volatility, JAGX or SNGX?

Summary

How does Jaguar Animal Health compare to Biomerica?

Which has more volatility & risk, JAGX or BMRA?

Does the media prefer JAGX or BMRA?

Do insiders and institutionals have more ownership in JAGX or BMRA?

Do analysts rate JAGX or BMRA?

Which has better valuation and earnings, JAGX or BMRA?

Is JAGX or BMRA more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

JAGX vs. The Competition

Jaguar Animal Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools